Sluggish Cognitive Tempo and ADHD: La Même Chose?

References (13)

1. Kamradt JM, Momany AM, Nikolas MA. Sluggish cognitive tempo symptoms contribute to heterogeneity in adult attention-deficit hyperactivity disorder. J Psychopathol Behav Assess. 2018;40(2):206–223. PubMed CrossRef
2. Becker SP, Leopold DR, Burns GL, et al. The internal, external, and diagnostic validity of sluggish cognitive tempo: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 2016;55(3):163–178. PubMed CrossRef
3. Leopold DR, Christopher ME, Burns GL, et al. Attention-deficit/hyperactivity disorder and sluggish cognitive tempo throughout childhood: temporal invariance and stability from preschool through ninth grade. J Child Psychol Psychiatry. 2016;57(9):1066–1074. PubMed CrossRef
4. Becker SP, Burns GL, Garner AA, et al. Sluggish cognitive tempo in adults: psychometric validation of the Adult Concentration Inventory. Psychol Assess. 2018;30(3):296–310. PubMed CrossRef
5. Moruzzi S, Rijsdijk F, Battaglia M. A twin study of the relationships among inattention, hyperactivity/impulsivity and sluggish cognitive tempo problems. J Abnorm Child Psychol. 2014;42(1):63–75.  PubMed CrossRef
6. Adams ZW, Milich R, Fillmore MT. A case for the return of attention-deficit disorder in DSM-5. ADHD Rep. 2010;18(3):1–6. CrossRef
7. Fassbender C, Krafft CE, Schweitzer JB. Differentiating SCT and inattentive symptoms in ADHD using fMRI measures of cognitive control. Neuroimage Clin. 2015;8:390–397. PubMed CrossRef
8. Marshall SA, Evans SW, Eiraldi RB, et al. Social and academic impairment in youth with ADHD, predominately inattentive type and sluggish cognitive tempo. J Abnorm Child Psychol. 2014;42(1):77–90. PubMed CrossRef
9. Becker SP, Langberg JM. Sluggish cognitive tempo among young adolescents with ADHD: relations to mental health, academic, and social functioning. J Atten Disord. 2013;17(8):681–689. PubMed CrossRef
10. Huang-Pollock CL, Nigg JT, Carr TH. Deficient attention is hard to find: applying the perceptual load model of selective attention to attention deficit hyperactivity disorder subtypes. J Child Psychol Psychiatry. 2005;46(11):1211–1218. PubMed CrossRef
11. Wietecha L, Williams D, Shaywitz S, et al. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. J Child Adolesc Psychopharmacol. 2013;23(9):605–613. PubMed CrossRef
12. Naguy A, Al-Enezi N, AlShalabi SR. Atomoxetine in-focus! Asian J Psychiatr. 2020;49:101634. PubMed CrossRef
13. Fırat S, Gul H, Aysev A. An open-label trial of methylphenidate treating sluggish cognitive tempo, inattention, and hyperactivity/impulsivity symptoms among 6- to 12-year-old ADHD children: what are the predictors of treatment response at home and school? J Atten Disord. 2021;25(9):1321–1330. PubMed CrossRef